Mosaic ImmunoEngineering Competitors and Similar CompaniesClear all
Mosaic ImmunoEngineering's competitors and similar companies include Senda Biosciences, NextCure, TC BioPharm and Bolt Biotherapeutics.
 Mosaic ImmunoEngineering Mosaic ImmunoEngineering (formerly known as Patriot Scientific Corporation) is a biotechnology company focused on bridging immunology and engineering to develop immunotherapies to treat and prevent cancer and infectious diseases. |  Senda Biosciences Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. |  Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | |
Founding Date | Founding Date 1987 | Founding Date 2017 | Founding Date 2015 | Founding Date 2013 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Carlsbad, US HQ | Locations Cambridge, US HQ | Locations Beltsville, US HQ | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB | Locations Redwood City, US HQ |
Employees | Employees 1 | Employees 16 | Employees N/A | Employees 41 | Employees 5248% decrease |
Valuation ($) | Valuation ($) 6.5 m | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) 926.7 k | Valuation ($) 25.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) |
Net income | Net income ($687.8k) (FY, 2025) | Net income N/A | Net income ($55.8m) (FY, 2025) | Net income (£12.2m) (FY, 2024) | Net income ($33.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 160m | Total funding raised $ 33.2m | Total funding raised $ 177.5m |
For sources of this data, please see the company profile
View Company Profiles
Senda Biosciences
HQ
Cambridge, US
Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes.
View companyNextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View companyTC BioPharm
HQ
Holytown, GB
Employees
41
TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
View companyBolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company